Intravascular Imaging Forum-1
|
10:30-12:50 102C |
|---|
| 主持 Moderators | 曾和松 Hesong ZENG, 李春坚 Chunjian LI, 董樑 Liang DONG | ||
| 讨论嘉宾 Discussants | 金戈 Ge JIN, 张文斌 Wenbin ZHANG, 张建勤 Jianqin ZHANG, 高立建 Lijian GAO | ||
|
10:30-10:35 |
开场致辞：匠心淬炼，县域同行 Opening Remarks |
王建安 Jianan WANG | |
|
10:35-10:55 |
心脏重症诊疗助力心脏亚专业发展 Cardiac Critical Care: Facilitating the Development of Heart Subspecialties |
于波 Bo YU | |
|
10:55-11:15 |
前瞻展望：IVUS和FFR的最新循证解读 Forward-looking Perspective: The Latest Evidence-based Interpretation of IVUS and FFR |
胡新央 Xinyang HU | |
|
11:15-11:35 |
重磅发布：IVUS 123标准化诊疗流程发布 Major Release: Launch of the IVUS 123 Standardized Diagnosis and Treatment Protocol |
董樑 Liang DONG | |
|
11:35-11:50 |
精工创韧：IVUS指导钙化病变的手术策略及经验分享 IVUS-Guided PCI Strategy of Calcified Lesions |
单培仁 Peiren SHAN | |
|
11:50-12:05 |
敏行纳新：IVUS指导ACS病变的手术策略及经验分享 IVUS-Guided PCI Strategy of ACS Lesions |
陆建洪 Jianhong LU | |
|
12:05-12:20 |
前沿守厚：人工智能助力腔内影像学实践应用 How Artificial Intelligence Empowers the Practical Application of Intravascular Imaging |
王启平 Qiping WANG | |
|
12:20-12:35 |
山海匠心：IVUS指导ISR病变的手术策略及经验分享 IVUS-Guided PCI Strategy of ISR Lesions |
范云操 Yuncao FAN | |
|
12:35-12:50 |
精益求精：IVUS指导弥漫病变的手术策略及经验分享 IVUS-Guided PCI Strategy of Diffuse Lesions |
龚心琰 Xinyan GONG | |
Coronary Antithrombosis Forum-1
|
13:30-15:30 102C |
|---|
| 主持 Moderators | Roopali KHANNA, 李毅 Yi LI, 刘震宇 Zhenyu LIU, 戴宇翔 Yuxiang DAI, 王贺阳 Heyang WANG | ||
|
13:30-13:50 |
ULTIMATE-DAPT研究揭示：ACS患者PCI后早期转为替格瑞洛单药的疗效 Ticagrelor alone Versus Ticagrelor Plus Aspirin from Month 1 to Month 12 after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes (ULTIMATE-DAPT) |
陈绍良 Shaoliang CHEN | |
|
13:50-14:10 |
REC-CAGEFREE II试验结果：DCB治疗后短期DAPT接替格瑞洛单药是否可行？ Randomized Evaluation of 5-Month Ticagrelor Monotherapy After 1-Month Dual-Antiplatelet Therapy in Patients With Acute Coronary Syndrome Treated With Drug-Coated Balloons: REC-CAGEFREE II Trial |
陶凌 Ling TAO | |
|
14:10-14:30 |
CATRX Technology & Trial: Is There A Role for Thrombus Aspiration | Dongming HOU | |
|
14:30-14:50 |
优化抗板方向-OPT-PEACE/EA-OUTCOME/TARGET SAFE等 Navigating the Future of Antiplatelet Therapy: Balancing Efficacy and Safety from the OPT-PEACE Study |
韩雅玲 Yaling HAN | |
|
14:50-15:10 |
TBD | Kent SO | |
|
15:10-15:30 |
讨论 Discussion |
||
Coronary Antithrombosis Forum-2
|
15:30-17:30 102C |
|---|
| 主持 Moderators | 蒋峻 Jun JIANG, 袁晋青 Jinqing YUAN, 于雪 Xue YU, 张波 Bo ZHANG | ||
|
15:30-15:50 |
血栓/缺血风险评分方向 Thrombotic or Ischemic Risk Scoring Strategy |
赵雪燕 Xueyan ZHAO | |
|
15:50-16:10 |
氯吡格雷 versus 阿司匹林单药治疗在经皮冠状动脉介入治疗后高心血管事件风险患者中的疗效与安全性（SMART-CHOICE 3研究） Efficacy and Safety of Clopidogrel Versus Aspirin Monotherapy in Patients at High Risk of Subsequent Cardiovascular Event after Percutaneous Coronary Intervention (SMART-CHOICE 3 Trial) |
Joo Myung LEE | |
|
16:10-16:30 |
OCT指导下冠脉精准介入与优化抗栓 Optical Coherence Tomography-Guided Precision Coronary Intervention and Optimized Antithrombotic Therapy |
贾海波 Haibo JIA | |
|
16:30-16:50 |
高出血风险患者的双联抗血小板治疗 DAPT in High Bleeding Risk Patients |
Jeehoon KANG | |
|
16:50-17:10 |
BRIGHT-4研究解读 Interpretation of the BRIGHT-4 Study |
李毅 Yi LI | |
|
17:10-17:30 |
TAILORED-CHIP Trial: Tailed antiplatelet therapy for High-risk Complex CHIP PCI | Duk-Woo PARK | |